Clinical Trials Sponsored by C3i Center Inc.
Total 4894 results
-
M.D. Anderson Cancer CenterGenentech, Inc.TerminatedHepatocellular Carcinoma | Cholangiocarcinoma | Liver CancerUnited States
-
M.D. Anderson Cancer CenterEisai Inc.Completed
-
M.D. Anderson Cancer CenterGenentech, Inc.; Vanderbilt-Ingram Cancer CenterCompletedLung CancerUnited States
-
Susan Chi, MDBristol-Myers Squibb; Epizyme, Inc.RecruitingChordoma | Epithelioid Sarcoma | Atypical Teratoid Rhabdoid Tumor | INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors | SMARCA4-deficient Primary CNS Malignant Tumors | Malignant Rhabdoid Tumor (MRT) | Rhabdoid Tumor of the Kidney (RTK)United States
-
M.D. Anderson Cancer CenterHiberCell, Inc.Not yet recruitingAcute Myeloid LeukemiaUnited States
-
Fox Chase Cancer CenterGenentech, Inc.Recruiting
-
M.D. Anderson Cancer CenterEisai Inc.RecruitingTumor | Brain MetastasesUnited States
-
M.D. Anderson Cancer CenterDNAtrix, Inc.RecruitingRecurrent Glioblastoma | Recurrent Malignant Glioma | Recurrent Gliosarcoma | Recurrent Anaplastic Astrocytoma | IDH1 wt AlleleUnited States
-
EpicentRx, Inc.Texas Children's Cancer CenterActive, not recruitingUnspecified Childhood Solid Tumor, Protocol Specific | Central Nervous System Neoplasms | Brain Tumor, Recurrent | Brain Tumor, PediatricUnited States
-
ExCellThera inc.Fred Hutchinson Cancer CenterActive, not recruitingHigh Risk Hematological Malignancy | Cord Blood TransplantUnited States, Netherlands
-
Jonsson Comprehensive Cancer CenterJanssen Inc.Active, not recruitingRecurrent Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Prostate Adenocarcinoma With Focal Neuroendocrine DifferentiationUnited States
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
M.D. Anderson Cancer CenterSeagen Inc.Terminated
-
Sanaria Inc.Fred Hutchinson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterEisai Inc.Completed
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.Completed
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.Completed
-
Jonsson Comprehensive Cancer CenterNantCell, Inc.No longer available
-
M.D. Anderson Cancer CenterImmunoGen, Inc.Completed
-
M.D. Anderson Cancer CenterCentocor, Inc.CompletedLeukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterBioTex, Inc.CompletedBone Metastases | Advanced CancerUnited States
-
M.D. Anderson Cancer CenterEisai Inc.WithdrawnAdvanced Cancer | Malignant Neoplasms of Female Genital Organs | Malignant Neoplasm of Breast | Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Malignant Neoplasms of Independent (Primary) Multiple Sites | Malignant Neoplasms... and other conditions
-
M.D. Anderson Cancer CenterMyrexis Inc.CompletedAssociation of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to CapecitabineBreast CancerUnited States
-
Case Comprehensive Cancer CenterGenentech, Inc.WithdrawnSingle Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD)Post-transplant Lymphoproliferative Disorder | PTLD
-
M.D. Anderson Cancer CenterEisai Inc.CompletedPancreatic Cancer | Venous ThromboembolismUnited States
-
Fox Chase Cancer CenterGenentech, Inc.WithdrawnStage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | Stage I Adult Diffuse Large Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
M.D. Anderson Cancer CenterEisai Inc.CompletedAcute Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.TerminatedCervical Cancer | Uterine CancerUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Withdrawn
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
M.D. Anderson Cancer CenterEisai Inc.CompletedSarcoma | Nausea | VomitingUnited States
-
M.D. Anderson Cancer CenterEisai Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterBioTex, Inc.Terminated
-
M.D. Anderson Cancer CenterEisai Inc.TerminatedChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedPancreatic CancerUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Terminated
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
M.D. Anderson Cancer CenterEisai Inc.TerminatedRenal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterSobi, Inc.Not yet recruiting
-
M.D. Anderson Cancer Center280Bio IncRecruitingMetastatic Pancreatic CancerUnited States
-
Vanderbilt-Ingram Cancer CenterGenentech, Inc.RecruitingStage IV Lung Cancer | Extensive Stage Lung Small Cell CarcinomaUnited States
-
Fred Hutchinson Cancer CenterImmunoGen, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm | Mixed Phenotype Acute LeukemiaUnited States
-
M.D. Anderson Cancer CenterAgenus Inc.RecruitingOropharyngeal Cancer | HPVUnited States
-
M.D. Anderson Cancer CenterOncoceutics, Inc.RecruitingRecurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruitingNon-Small Cell Lung Cancer | Lung CancerUnited States
-
Fox Chase Cancer CenterOncoceutics, Inc.Terminated
-
Jonsson Comprehensive Cancer CenterViewray Inc.Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than 0.03 | Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7United States
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruiting